Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Ketamine for mood disorders. Lansdale: HAYES, Inc.. Directory Publication. 2012 Authors' conclusions Intravenous injection of ketamine hydrochloride is intended to reduce symptoms of depression in patients with treatment-resistant depression. Indexing Status Subject indexing assigned by CRD MeSH Humans; Ketamine; Mood Disorders Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32013000192 Date abstract record published 25/03/2013 |